Epimedin C, icariin, icaritin dirhamnoside, baohuoside I, rutin, isoquercitrin, neohesperidin, glucohesperetin, naringin, prunin, myricetrin, myricetin, vitexin, dioscin, zingiberensis newsaponin, ginsenoside Rg2, and ginsenoside Re were all purchased from Sichuan Weikeqi Biotechnology Co., Ltd (China).

Rat interleukin (IL)-1β, IL-6, tumor necrosis factor alpha (TNF-α) enzyme-linked immunosorbent assay (ELISA) kit was obtained from Multi Science Biotechnology Co., Ltd. (Hangzhou, China). Reference standards of ferulic acid, atractylodin, tanshinone, astragaloside, hyperoside, loganin, gallic acid, morroniside, allantoin, oleanic acid, ginsenoside Rb1, ginsenoside Re, ginsenoside Rg1, paeoniflorin, vaccarin, pyrrolidinium, leonurine, and catalpol were obtained from Sichuan Weikeqi Biological Technology Co., Ltd. (Sichuan, China).

The reference standards of notoginsenoside R1, ginsenosides Rg1, Re, Rb1, Rc, 20(S)–Rh1, 20(R)-Rh1, Rd, Rg6, F4, Rk3, Rh4, 20(S)-Rg3, 20(R)-Rg3, Rk1, and Rg5, all with a purity ≥98%, were purchased from Sichuan Weikeqi Biological Technology Co., Ltd. (Chengdu, Sichuan, China). EPO was purchased from Chengdu Di'ao Jiuhong Pharmaceutical Factory (Chengdu, Sichuan, China). FEJ was purchased from Shandong Dong'e E'jiao Co., Ltd.

Liquiritin apioside, liquiritin, neoliquiritin, isoliquiritin apioside, isoliquiritin, ononin, naringin, liquiritigenin, poricoic acid A, poricoic acid B, poricoic acid C, glycyrrhetinic acid, dehydropachymic acid, pachymic acid, ginsenoside Re, ginsenoside Rg1, ginsenoside Rf, isoliquiritigenin, ginsenoside Rb1, ginsenoside Rg2, ginsenoside Rg3, ginsenoside Rg5, 20(S)-ginsenoside Rh1, notoginsenoside R1, ginsenoside Ro, ginsenoside Rc, formononetin, ginsenoside Rb2, glycyrrhizic acid, ginsenoside Rd, ginsenoside Rk1, and atractylenolide III were purchased from Chengdu DeSiTe Biological Technology Co., Ltd. (Chengdu, China) or Sichuan Weikeqi Biological Technology Co., Ltd. (Chengdu, China).

To define effects of Ang II and G-Re on hemodynamics, Ang II and G-Re (Sichuan Weikeqi Biological Technology, Sichuan, China) were infused into rats anesthetized with pentobarbital sodium (3%, 3 mL/kg) (Table 1). After exposure with a longitudinal incision in the groin and neck

Notoginsenoside R1 reference standard was purchased from the Nature Standard Biological Technology Co., Ltd (Shanghai, P. R. China) (lot: STA-25613013, ≥98%). Ginsenoside Rg1 (lot: 110626, ≥98%), Ginsenoside Re (lot: 110819, ≥98%), Ginsenoside Rb1 (lot: 110723, ≥98%) were purchased from Sichuan Weikeqi Biological Technology Co., Ltd, and Ginsenoside Rd, Sichuan, P. R. China (lot: 111818-Q7201302, ≥94.2%) was purchased from the National Institute for Food and Drug Control.

Qualitative and quantitative analyses of SPN were performed as previous report (Xiong et al., 2017a). In brief, notoginsenoside R1 and ginsenosides Rg1, Re, 20(R)-Rh1, Rb1, Rd, Rk3, Rh4, 20(S)-Rg3, 20(R)-Rg3 (Sichuan Weikeqi Biological Technology Co., Ltd. Sichuan, China) with purity ≧ 98% were used as standard compounds. The analysis was performed on an Agilent 1260HPLC system (Agilent Technologies) equipped with a G1311B Pump, a G4212B DAD detector, and a G1329B autosampler.

Recombinant human UGT isoforms (UGT1A1, UGT1A6, UGT1A7, UGT1A8, UGT1A9, UGT1A10, UGT2B7, UGT2B15) expressed in baculovirus-infected insect cells were obtained from BD Gentest Corp. (Woburn, MA, USA). Ginsenosides Rb1, Rb2, Rc, Rd, Rg3, Rh2, C-K, ppd, ppt, Re, Rg1, Rh1, F1, and F2 were purchased from Sichuan Weikeqi Biotechnology Company (Chengdu, Sichuan, China). The purity of these compounds was above 95%. All other reagents were of HPLC grade or of the highest grade commercially available.

Acetonitrile of chromatographic grade and ferrous chloride and hydrogen peroxide of analytical grade were purchased from Merck Chemical Co. (Darmstadt, Germany). Notoginsenoside R1, ginsenosides Rg1, Re, Rb1, Rd, Rh1, Rk3, Rh4, 20(S)-Rg3, and 20(R)-Rg3 (Sichuan Weikeqi Biological Technology Co., Ltd. Chengdu, China) with a purity ≥ 98% were used as the standard compounds.